ozempic semaglutide patent expiry Novo Nordisk to Launch in India Before in March 2026 Several Indian companies have firmed
Description
Most people regain weight after discontinuing semaglutide, but structured maintenance strategies and genetic insights can help preserve your progress
To read the FULL show notes, visit Click the Podcast tab, and select episode 269
Semaglutide subcutaneous injection and oral tablets are used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus (T2DM)
At week 156, oral semaglutide maintained significant reductions in HbA1c (ETD 0.47%
